B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ponatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ponatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rebastinib
53 shared targets
bafetinib
28 shared targets
saracatinib
33 shared targets
nilotinib
38 shared targets
cep
29 shared targets
doramapimod
41 shared targets
tivozanib
27 shared targets
golvatinib
27 shared targets
regorafenib
25 shared targets
vandetanib
45 shared targets
Loading evidence profile...

This evidence profile for Ponatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.